ImmunityBio (IBRX) Other Working Capital Changes (2014 - 2026)

ImmunityBio (IBRX) has 8 years of Other Working Capital Changes data on file, last reported at $16000.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 93.42% year-over-year to $16000.0 in Q1 2026; TTM through Mar 2026 was $376000.0, a 35.25% increase from a year earlier, with the FY2025 full-year figure at $570000.0, up 422.94% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $16000.0, down from $82000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for IBRX reached as high as $14.3 million in Q2 2022 and fell as low as -$11.6 million in Q4 2025.
• Historically, Other Working Capital Changes has averaged $747117.6 across 5 years, with a median of $1.3 million in 2026.
• Across the five-year window, Other Working Capital Changes tumbled 118.41% in 2024 and surged 11328.57% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $2.6 million in 2022, then tumbled by 92.19% to $201000.0 in 2023, then plunged by 118.41% to -$37000.0 in 2024, then soared by 321.62% to $82000.0 in 2025, then sank by 80.49% to $16000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $16000.0 in Q1 2026, $82000.0 in Q4 2025, and $35000.0 in Q3 2025.